Tarsus Pharmaceuticals TARS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 81.88 | 194.54 | -0.19 | -7,976 | -8 | |
| 2025Q3 | 59.43 | 140.83 | -0.30 | -14,529 | -13 | |
| 2025Q2 | 40.51 | 122.56 | -0.48 | -22,184 | -20 | |
| 2025Q1 | 51.37 | 114.72 | -0.64 | -26,280 | -25 | |
| 2024Q4 | 55.37 | 120.84 | -0.59 | -24,421 | -23 | |
| 2024Q3 | 32.89 | 119.96 | -0.59 | -25,162 | -23 | |
| 2024Q2 | 27.18 | 108.87 | -0.88 | -33,302 | -33 | |
| 2024Q1 | 36.35 | 110.31 | -1.01 | -37,684 | -36 | |
| 2023Q4 | 20.25 | 107.54 | -1.27 | -44,450 | -42 | |
| 2023Q3 | 17.77 | 107.22 | -1.30 | -40,935 | -39 | |
| 2023Q2 | 18.07 | 107.17 | -1.17 | -32,821 | -31 | |
| 2023Q1 | 12.57 | 110.07 | -0.88 | -24,952 | -23 | |
| 2022Q4 | 14.66 | 116.17 | -0.49 | -15,061 | -14 | |
| 2022Q3 | 17.12 | 104.74 | -0.88 | -22,906 | -23 | |
| 2022Q2 | 14.60 | 97.19 | -0.17 | -5,224 | -6 | |
| 2022Q1 | 16.82 | 98.95 | -0.98 | -19,521 | -20 | |
| 2021Q4 | 22.50 | 101.70 | -0.72 | -14,448 | -15 | |
| 2021Q3 | 21.55 | 98.02 | -0.71 | -15,705 | -16 | |
| 2021Q2 | 28.98 | 114.37 | 0.29 | 7,282 | 6 | |
| 2021Q1 | 32.23 | 100.32 | 0.47 | 10,714 | 10 |